The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Labinger Barry since 2006.
The trader's CIK number is 1332456.
At the time of the last reporting, Labinger Barry was the Exec VP & CCO of Emergent Biosolutions Inc.. (stock ticker symbol EBS).
Also see all insider trading activities at Emergent Biosolutions Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2012 | HGSI | 0 | $0 | 0 | $0 | 31,480 | $85,625 |
| 2011 | HGSI | 0 | $0 | 47,313 | $1,419,390 | 65,675 | $301,849 |
| 2010 | HGSI | 0 | $0 | 101,000 | $2,922,961 | 101,000 | $400,686 |
| 2009 | HGSI | 0 | $0 | 69,696 | $1,907,579 | 24,996 | $12,997 |
| 2006 | HGSI | 0 | $0 | 5,300 | $51,886 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2015 | EBS | 0 | $0 | 39,502 | $1,410,822 | 29,562 | $688,626 |
1. Human Genome Sciences Inc (HGSI)
2. Emergent Biosolutions Inc. (EBS)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2012-07-25 | HGSI | Option Ex | 31,480 | 2.72 | 85,625 |
| 2011-07-26 | HGSI | Option Ex | 18,362 | 8.55 | 156,995 |
| 2011-05-02 | HGSI | Option Ex | 7,347 | 4.92 | 36,147 |
| 2011-05-02 | HGSI | Sale | 7,347 | 30.00 | 220,410 |
| 2011-04-28 | HGSI | Option Ex | 39,966 | 2.72 | 108,707 |
| 2011-04-28 | HGSI | Sale | 39,966 | 30.00 | 1,198,980 |
| 2010-09-01 | HGSI | Sale | 50,000 | 30.02 | 1,500,800 |
| 2010-09-01 | HGSI | Option Ex | 50,000 | 4.92 | 246,000 |
| 2010-08-26 | HGSI | Sale | 13,050 | 28.53 | 372,355 |
| 2010-08-27 | HGSI | Option Ex | 16,079 | 4.92 | 79,108 |
| 2010-08-26 | HGSI | Option Ex | 13,050 | 4.92 | 64,206 |
| 2010-08-27 | HGSI | Sale | 16,079 | 28.50 | 458,283 |
| 2010-07-26 | HGSI | Option Ex | 21,871 | .52 | 11,372 |
| 2010-07-26 | HGSI | Sale | 21,871 | 27.05 | 591,523 |
| 2009-11-30 | HGSI | Option Ex | 24,996 | .52 | 12,997 |
| 2009-11-30 | HGSI | Sale | 69,696 | 27.37 | 1,907,579 |
| 2006-08-16 | HGSI | Sale | 5,300 | 9.79 | 51,886 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2015-11-13 | EBS | Sale | 3,376 | 36.50 | 123,224 |
| 2015-11-12 | EBS | Sale | 10,094 | 36.00 | 363,384 |
| 2015-11-11 | EBS | Option Ex | 19,468 | 24.52 | 477,258 |
| 2015-11-12 | EBS | Option Ex | 10,094 | 20.94 | 211,368 |
| 2015-11-11 | EBS | Sale | 26,032 | 35.50 | 924,214 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Labinger Barry (Exec VP & CCO of Emergent Biosolutions Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.